Speakeasy Cannabis Club Ltd. announce that it has appointed Charles Williams, Ph.D as an additional independent director to its board of directors. As part of its growth strategy, SpeakEasy added critical talent to its leadership in 2020 including CEO Malcolm Davidson, a veteran of public company finance, management and marketing. Mr. Bill Fleming was elected as an independent director in February 2020 and as Chairman of the Board in January 2021. Mr. Fleming was previously President of Mernova Medicinal Inc, which recently sold to Switzerland-based Creso Pharma Inc. and is currently the President & CEO for Halucenex Life Sciences Inc., The Company announced that Mr. Ian Waddell has been appointed to SpeakEasy's Advisory Board. It is expected that Mr. Waddell will be appointed to the Board upon receipt of security clearance from Health Canada as an independent director.